https://ca-074inhibitor.com/is....olation-as-well-as-d
Optimizing the changeover from oral SGAs to their LAI counterparts hinges on a thorough understanding of LAI formulation pharmacokinetics and continuous monitoring of SGA levels during oral therapy. With LAI SGAs potentially leading the way in maintenance treatment for schizophrenia-spectrum disorders, their use may expand to address other severe mental illnesse
Like
Comment
Share
